ABBV vs MDGL · P/E 81, rev $61.16B vs rev $180.1M
AbbVie Inc (ABBV) versus Madrigal Pharmaceuticals Inc (MDGL) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported MDGL revenue for 2024-12-31 was $180.1M. Net income was -$465.9M. MDGL currently screens at market cap $11.56B.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. MDGL currently screens at market cap $11.56B.
Not investment advice. Open the ABBV and MDGL stock pages for the full models.
Not investment advice.